SCHEMBL14083795

SCHEMBL14083795

COc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(OC)c2)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ NAMPT P43490 2/20 0.54
▸ MEN1 O00255 5/20 0.52
▸ KMT2A Q03164 5/20 0.52
▸ CASP3 P42574 1/20 0.52
▸ SENP8 Q96LD8 1/20 0.52
▸ SENP7 Q9BQF6 1/20 0.52
▸ SENP6 Q9GZR1 1/20 0.52
▸ LMNA P02545 1/20 0.51
▸ KEAP1 Q14145 1/20 0.51
▸ NFE2L2 Q16236 1/20 0.51
▸ POLB P06746 3/20 0.50
▸ KCNQ3 O43525 2/20 0.50
▸ KCNQ2 O43526 2/20 0.50
▸ AURKB Q96GD4 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083313 0.92 SMN1; SMN2 (0.64) SMN1; SMN2NAMPTMEN1KMT2ACASP3
SCHEMBL14083788 0.91 KCNQ3 (0.62) SMN1; SMN2MEN1KMT2ALMNAPOLB
SCHEMBL14083686 0.90 KCNQ3 (0.53) SMN1; SMN2NAMPTMEN1KMT2ACASP3
SCHEMBL14083392 0.90 SMN1; SMN2 (0.56) SMN1; SMN2NAMPTMEN1KMT2ACASP3
SCHEMBL14083731 0.88 AURKB (0.54) SMN1; SMN2MEN1KMT2ACASP3SENP7
SCHEMBL14083766 0.88 LMNA (0.68) SMN1; SMN2NAMPTKMT2ALMNAPOLB
SCHEMBL14083835 0.87 AURKB (0.56) SMN1; SMN2MEN1KMT2ALMNAPOLB
SCHEMBL14083757 0.86 GRM4 (0.63) SMN1; SMN2MEN1KMT2ALMNAPOLB
SCHEMBL14083841 0.86 AURKB (0.55) MEN1KMT2ALMNAPOLBAURKB
SCHEMBL14083805 0.86 POLB (0.60) SMN1; SMN2MEN1KMT2ACASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 SMN1; SMN2 2099/4885NAMPT 1183/4885MEN1 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback